Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

NCT05156528 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

21000

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysentery
Shigellosis

Interventions

BIOLOGICAL: S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
BIOLOGICAL: Placebo

Sponsor

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd